ランキング
価格
はじめての方へ
ログイン
無料体験
米国企業
CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd
CLGN
時価総額
PER
マイリストに追加
マイリストに追加
サマリーテーブルに戻る
十億
百万
千
USD
ILS
年次
四半期
Download CSV
損益計算書
バランスシート
キャッシュフロー
2019年
12月31日
2020年
12月31日
2021年
12月31日
2022年
12月31日
Net income (loss)
-11
-
-0
-17
Depreciation and amortization
-
-
1
1
Interest from Short term deposits
-
-
0
0
Share-based compensation to employees and consultants
-
-
2
2
Exchange differences on cash and cash equivalents
-
0
0
-1
Financial income related to financial instruments
-
-0
-0
-
Decrease (increase) in trade receivables
-
1
-1
-0
Decrease (increase) in inventories
-
0
-0
0
Decrease (increase) in other receivables
-
-0
0
0
Decrease in operating right of use assets
-
-
-0
-0
Increase (decrease) in trade payables
-
-0
0
0
Decrease in lease liabilities
-
-
-0
-1
Increase (decrease) in accrued liabilities and other payables
-
1
-0
0
Decrease in deferred revenues
-
-1
-0
-0
Net cash provided by (used in) operating activities
-
-4
3
-14
Capitalization of intangible assets
-
0
0
0
Purchase of property and equipment
-
0
1
1
Repayment of a short term deposits
-
-
-
50
Investment in short term deposits
-
-
30
20
Proceeds from sale of property and equipment
-
-
0
-
Net cash provided by (used in) investing activities
-
-1
-32
29
Proceeds from issuance of shares and warrants less issuance expenses
-
4
33
-
Loan repaid
-
0
-
-
Exercise of options and warrants into shares
-
0
6
2
Net cash provided by financing activities
-
4
39
2
Exchange differences on cash and cash equivalents and restricted deposits
-
0
0
-1
Net increase (decrease) in cash and cash equivalents and restricted deposits
-
-
-
16
Conversion of pre-paid warrants to ordinary shares
-
0
-
-
Right of use assets recognized with corresponding lease liabilities
-
0
1
0
Classification of issuance costs liability to equity
-
-
0
-
Capitalization of Share-based compensation to inventory
-
-
-
0
Cash paid during the year for taxes
-
-
-
0